Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| ATOSSA GNTCS (NASDAQ: ATOS) | Delayed: 2.39 -0.05 (2.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.44 | 52 Week High | $3.64 | |||
| Open | $2.44 | 52 Week Low | $0.14 | |||
| Day High | $2.53 | P/E | N/A | |||
| Day Low | $2.34 | EPS | $0.00 | |||
| Volume | 81,420 | |||||
